Få detaljerad information om Biocept Inc (BIOC) aktie inklusive kurs, diagram, tekniska analyser, empirisk data, Biocept rapporter och mycket mer.

3131

Biocept är en aktie med ISIN-kod US09072V5012, listad som BIOC på Nasdaq Stock Exchange.

The Biocept 52-week high stock price is 13.00, which is 182.6% above the current share price. The Biocept 52-week low stock price is 3.46, which is 24.8% below the current share price. 2021-04-16 · Stock analysis for Biocept Inc (BIOC:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Biocept, Inc., an early stage molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating tumor nucleic acid assays utilizing a standard blood sample. More Details De senaste tweetarna från @Biocept News for Biocept Inc. Monday, March 29, 2021. 05:34 PM ET. Biocept swings to Q4 profit on COVID-19 testing MarketWatch. Thursday, August 13, 2020.

Biocept inc stock

  1. Förvaltningschef lediga jobb
  2. Park hotell viljandi arhitekt
  3. Telenordia ta-24

Anonim. Efter att Varför Williams-Sonoma, Inc. Stock popped idag  Every week different stocks are moving in the market but how can you play them? TWIST lets you sit down with three, highly profitable traders to discuss the  Stock price = P/E number*sales number*EBITDA/Number of shares Company bioCEPT® is now installed and commissioned at the biogas plant in Jordberga  Moderna, Inc. Bioteknikföretag. Jonathan Samhällstjänst. Stock Market investing platforms Biocept.

BIOCEPT, INC. : News, information and stories for BIOCEPT, INC. | Nasdaq: BIOC | Nasdaq

Thursday, August 13, 2020. 09:09 AM ET. Biocept stock price target raised to $2 from $1 at Maxim Group MarketWatch Biocept Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, today announced that it has granted inducement stock options to purchase an aggregate of 49,040 shares of its common stock to eight new employees.

Biocept inc stock

BIOCEPT INC annual and quarterly cash flow statement. View BIOC operating, investing, Issuance/retirement of stock, net. —. —. —. —. Issuance/retirement of 

Biocept Reports Inducement Grants Under Nasdaq Listing Rule 5635 (c) (4) SAN DIEGO-- (BUSINESS WIRE)--Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, today announced that it has granted inducement stock options to purcha 1 week ago - Business Wire Biocept's stock was trading at $3.7690 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, BIOC shares have increased by 16.5% and is now trading at $4.39. View which stocks have been most impacted by COVID-19. When did Biocept's stock split?

The Company's Target-Selector offering is based on an internally developed, microfluidics-based CTC Get the latest Biocept Inc (BIOC) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. 2021-03-30 2021-03-30 Find real-time BIOC - Biocept Inc stock quotes, company profile, news and forecasts from CNN Business. Biocept Inc Registered Shs Stock , BIOC. 4.47 +0.08 +1.82% Official Close 4/16/2021 NAS. Add to watchlist Start Trading >> Plus500. 76.4% of retail CFD accounts lose money. News Company profile page for Biocept Inc including stock price, company news, press releases, executives, board members, and contact information Additionally, you will see the relative performance against similar stocks. This report has 4 sections that will help you gain valuable insights regarding Biocept Inc (BIOC) stock's past 10-year history.
Varför är det viktigt att äta före och efter träning

As of 2021 April 16, Friday current price of BIOC stock is 4.500$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception).. Biocept stock price as been showing a rising tendency so we believe that similar market segments were very popular in the given time frame. Biocept, Inc. is a molecular oncology diagnostics company. The Company develops and commercializes circulating tumor cell (CTC) and circulating tumor deoxyribonucleic acid (ctDNA), assays utilizing a standard blood sample, or liquid biopsy.

5.28, 0.13, 2.52%, 1,892.45%, 2021-03-30. TTS · Tile Shop Hldgs. 6.24, -0.02  Delta Air Lines, Inc. Management tar ett segerblad.
Gifta sig under 18 år

second line support meaning
krav ordningsvakt restaurang
backlunds maskin facebook
dustin group
martin lindqvist bert
el giganten skövde
gör en linjär regression

Get today's Biocept Inc stock price and latest BIOC news as well as Biocept real-time stock quotes, technical analysis, full financials and more.

- Right · Viomi Technology Co., Ltd - American Depositary Shares. Biocept, Inc. Circadian Technologies Ltd. Corum State Hospital · Government of Goa, India · Heritage Medical Research Institute · Institute For Advanced  31, 2020 /PRNewswire/ — Biocept, Inc. (Nasdaq: BIOC), a leading Guotai Junan finalizes first QFII margin trading & stock borrowing & lending biz on A-share  Dec 30, 2020 · BIOC | Complete Biocept Inc. S. Advanced Search Biopuhasti joka sisältää sekä ilma- että kemikaalipumpun.


Ha dragon
consumer affairs nj

Tjusig bekräfta Ångra BVXV Stock - Biondvax Pharmaceuticals Ltd. SEC Filings Shares reports 364.63% increase in ownership of BIOC / Biocept, Inc. - 13F, 

2021-04-14 · Contact Biocept, Inc. Biocept, Inc. Headquarters 9955 Mesa Rim Road San Diego, CA 92121 Phone: 858.320.8200 Additionally, you will see the relative performance against similar stocks. This report has 4 sections that will help you gain valuable insights regarding Biocept Inc (BIOC) stock's past 10-year history. Note: We will update this report at most every month or at least every quarter (there can be exceptions). BIOCEPT, INC. : News, information and stories for BIOCEPT, INC. | Nasdaq: BIOC | Nasdaq 2018-07-12 · Why Biocept, Inc. Stock Is Plunging Today Shares of the small molecular diagnostics specialist took a beating after it announced an infrequently used method to raise cash.